America Great Health (AAGH)

[Penny Stocks 2.0]

Effective June 22, 2017, the Board of Directors (the "Board") of America Great Health   (the "Company") determined that it was in the best interest of the Company to separate the role of President from the role of Chief Executive Officer ("CEO"). Accordingly, the Board approved the appointment of Herric Chan as the Company's CEO replacing Mike Q. Wang.


Mr. Chan, age 46, has 20 years extensive business experiences across investment banking, lending, real estate, sales & marketing, biotech, healthcare, and pharmaceutical industry. He currently serves as Director of Alliance Capital Group (Hong Kong) servicing the IPO, financial advisory, and asset management in Hong Kong and China markets; Associate Partner of Chimera Co. Ltd. (Thailand), a financial advisory and asset management firm servicing South East Asia and Taiwan markets; and CEO of Round Table Group, (California, CalBRE #02022089) a licensed brokerage firm in the US specializes in multinational M&A and commercial real estate markets..


Prior to current positions, Mr. Chan served as Managing Director at Evidia Biosciences, a clinical laboratory and pathology service provider consists of 3 labs servicing over 700 physicians in Southern California and Pennsylvania; Vice President at Amphastar Pharmaceutical, (NASDAQ:AMPH); and Director of International Society of Pharmaceutical Engineers (ISPE, 18,000 members in 90 countries worldwide) LA. Ch. Mr. Chan started his investment banking career back in 1990 as Operation Manager of Tse's Investment Ltd., the investment division of TSL, Ltd. (0417.HK), running stock and forex investment floor with 6 trading offices throughout HK.